This study compared urinary OCP levels in T1D patients and healthy subjects and evaluated their association with the condition. We observed higher urinary concentrations of p,p'-DDD in diabetic children compared to controls, along with significant positive associations between the highest levels of p,p'-DDD, and T1D. Moreover, we noted a higher OR of T1D in participants with a medium level of urinary β-BHC compared to those with the lowest level.
Recent evidence underscores the significant role of environmental factors, particularly EDCs, in the pathogenesis of T1D, suggesting them as key contributors to the rising global incidence of T1D (
4-
6).
Despite mounting evidence of an association between OCP exposure and T1D, existing literature faces several challenges. Most studies are cross-sectional or case-control, with inconsistencies in the types of OCPs measured and measurement methods across studies. As an initial study in our region, we conducted the current research.
Our literature review uncovered studies exploring the impact of prenatal and early-life exposure to OCPs on T1D development (
17,
18).
In a case-control study conducted in Sweden involving 150 children diagnosed with T1D and 150 age and birth-day-matched controls, researchers assessed the levels of p,p’-DDE in mothers' stored serum during pregnancy. The concentrations of p,p’-DDE were similar between the T1D cases and controls (9.2 vs. 9.6 ng/mL, respectively) and showed a decrease over time. The findings did not support the hypothesis that prenatal exposure to persistent organic pollutants (POPs) increases the risk of developing T1D (
17).
In the FINDIA and DIABIMMUNE birth cohort studies, researchers investigated the association between early-life exposure to environmental pollutants and the risk of developing diabetes-predictive autoantibodies in children genetically susceptible to T1D. They measured levels of various POPs and per and polyfluorinated substances in cord blood and plasma samples from infants at 12 and 48 months of age. No significant link was found between exposure to these environmental chemicals and the development of clinical T1D, suggesting that fetal or early childhood exposure does not significantly increase the risk of β-cell autoimmunity and T1D (
18).
A study in Egypt found that children newly diagnosed with T1D had higher serum levels of eight out of nine evaluated organochlorine and organophosphorus pesticides compared to healthy controls (
19). Lindane was the most frequently detected organochlorine pesticide among T1D patients (70.7%), followed by o,p’-DDD (21.3%), p,p’-DDE (21.3%), and endrin (10.7%), with malathion being the most commonly found organophosphorus compound (65.3% of cases). This suggested an increased risk of T1D in children exposed to these compounds (
19).
A recent study in the USA, using data and biological samples from the SEARCH-CC, explored the role of POPs in the onset of T1D among a well-characterized group of young individuals. Additionally, an experimental model was used to study the effects of POPs on β-cells. Elevated plasma levels of p,p’-DDE, trans-nonachlor, and PCB-153 were associated with an increased risk of T1D in patients with normal insulin sensitivity but not in those with insulin resistance (IR). Experimental findings showed that PCB-153 and p,p’-DDE significantly reduced insulin levels within cells and insulin secretion in pancreatic β-cells (
20).
The interpretation of these findings suggests that young patients with T1D who also exhibit IR possess a greater amount of adipose tissue or exhibit higher BMI and waist circumference compared to those with normal insulin sensitivity. This increased adipose tissue capacity allows T1D patients with IR to store higher levels of POPs, thereby reducing their circulating levels (
20).
In our study, among the OCPs analyzed, only the level of urinary p,p'-DDD was found to be elevated in diabetic patients, and a significant association between this metabolite and T1D was identified. Additionally, an increased level of β-BHC exposure may be associated with T1D.
Given the limited number of studies in this area and regional variations in pesticide use, as well as genetic differences among participants, our results could serve as foundational information for future research evaluating exposure sources and their effects.
Yang et al., in a study within the USA, explored the potential relationship between serum concentrations of OCPs and 25-hydroxyvitamin D (25(OH)D) levels in the general U.S. population, using data from the National Health and Nutrition Examination Survey (NHANES) 2003 - 2004. They found significant inverse associations between serum 25(OH)D levels and the OCPs detectable in over 80% of participants, specifically p,p’-DDT, p,p’-DDE, and β-hexachlorocyclohexane. Notably, p,p’-DDT showed consistent inverse associations across different subgroups, categorized by age, race, and chronic disease presence (
23).
Considering the role of vitamin D deficiency in the pathogenesis of T1D (
24,
25), it is suggested that OCP exposure may increase the risk of T1D among children with vitamin D deficiency. However, further research is needed in this area.
The limitations of our study include its case-control design, small sample size, the assessment of urinary OCP metabolites from a single urine sample, and the simple classification of pesticides. A strength of this study lies in the careful matching of the control group to the patient group in terms of age, sex, location, and novelty.
In conclusion, our study supports the potential role of p,p'-DDD, and β-BHC in the development of T1D. Considering the significant public health implications of this association, further research is essential to elucidate the mechanisms behind this relationship and to explore potential preventive strategies. For future studies, employing larger designs, increasing sample sizes, providing more precise pesticide classifications, and conducting a comprehensive analysis of various variables are recommended.